Cahill Represents ICON plc in Acquisition of Biotel Research
Date: 10/02/23
Cahill advised ICON plc, a global provider of outsourced drug and device development and commercialization solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organization, in its acquisition of Biotel Research LLC (formerly known as Philips Pharma Solutions), a leading provider of medical imaging and cardiac safety monitoring services.